{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:36:15Z","timestamp":1793050575421,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Natural Science key project of Bengbu Medical College","award":["No. 2021byzd064"],"award-info":[{"award-number":["No. 2021byzd064"]}],"id":[{"id":"https:\/\/ror.org\/01f8qvj05","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-98661-1","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T08:28:43Z","timestamp":1745569723000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["RETRACTED ARTICLE: Leucine rich repeat containing 15 promotes triple-negative breast cancer proliferation and invasion via the ITGB1\/FAK\/PI3K signalling pathway"],"prefix":"10.1038","volume":"15","author":[{"given":"Xiao","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yameng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinxi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zishu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiang","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,25]]},"reference":[{"key":"98661_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: Globocan estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"98661_CR2","doi-asserted-by":"publisher","first-page":"6276","DOI":"10.1038\/s41467-021-26502-6","volume":"12","author":"BD Lehmann","year":"2021","unstructured":"Lehmann, B. D. et al. Multi-omics analysis identifies therapeutic vulnerabilities in triple-negative breast cancer subtypes. Nat. Commun. 12, 6276. https:\/\/doi.org\/10.1038\/s41467-021-26502-6 (2021).","journal-title":"Nat. Commun."},{"key":"98661_CR3","doi-asserted-by":"publisher","first-page":"4429","DOI":"10.1158\/1078-0432.Ccr-06-3045","volume":"13","author":"R Dent","year":"2007","unstructured":"Dent, R. et al. Triple-negative breast cancer: Clinical features and patterns of recurrence. Clin. Cancer Res. 13, 4429\u20134434. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-06-3045 (2007).","journal-title":"Clin. Cancer Res."},{"key":"98661_CR4","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","volume":"321","author":"AG Waks","year":"2019","unstructured":"Waks, A. G. & Winer, E. P. Breast cancer treatment: A review. JAMA 321, 288\u2013300. https:\/\/doi.org\/10.1001\/jama.2018.19323 (2019).","journal-title":"JAMA"},{"key":"98661_CR5","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"CM Perou","year":"2000","unstructured":"Perou, C. M. et al. Molecular portraits of human breast tumours. Nature 406, 747\u2013752. https:\/\/doi.org\/10.1038\/35021093 (2000).","journal-title":"Nature"},{"key":"98661_CR6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071674","volume":"381","author":"RA Leon-Ferre","year":"2023","unstructured":"Leon-Ferre, R. A. & Goetz, M. P. Advances in systemic therapies for triple negative breast cancer. BMJ 381, e071674. https:\/\/doi.org\/10.1136\/bmj-2022-071674 (2023).","journal-title":"BMJ"},{"key":"98661_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13058-020-01296-5","volume":"22","author":"L Yin","year":"2020","unstructured":"Yin, L., Duan, J. J., Bian, X. W. & Yu, S. C. Triple-negative breast cancer molecular subtyping and treatment progress. Breast Cancer Res. 22, 61. https:\/\/doi.org\/10.1186\/s13058-020-01296-5 (2020).","journal-title":"Breast Cancer Res."},{"key":"98661_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104683","volume":"153","author":"KGK Deepak","year":"2020","unstructured":"Deepak, K. G. K. et al. Tumor microenvironment: Challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol. Res. 153, 104683. https:\/\/doi.org\/10.1016\/j.phrs.2020.104683 (2020).","journal-title":"Pharmacol. Res."},{"key":"98661_CR9","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1146\/annurev-pathol-042420-093238","volume":"17","author":"F Derakhshan","year":"2022","unstructured":"Derakhshan, F. & Reis-Filho, J. S. Pathogenesis of triple-negative breast cancer. Annu. Rev. Pathol. 17, 181\u2013204. https:\/\/doi.org\/10.1146\/annurev-pathol-042420-093238 (2022).","journal-title":"Annu. Rev. Pathol."},{"key":"98661_CR10","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1158\/0008-5472.Can-21-3734","volume":"82","author":"U Ray","year":"2022","unstructured":"Ray, U. et al. Exploiting lrrc15 as a novel therapeutic target in cancer. Can. Res. 82, 1675\u20131681. https:\/\/doi.org\/10.1158\/0008-5472.Can-21-3734 (2022).","journal-title":"Can. Res."},{"key":"98661_CR11","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3390\/cells13131094","volume":"13","author":"M Miron-Mendoza","year":"2024","unstructured":"Miron-Mendoza, M. et al. The role of vimentin in human corneal fibroblast spreading and myofibroblast transformation. Cells 13, 1094. https:\/\/doi.org\/10.3390\/cells13131094 (2024).","journal-title":"Cells"},{"key":"98661_CR12","doi-asserted-by":"publisher","first-page":"1121586","DOI":"10.3389\/fphar.2023.1121586","volume":"14","author":"J Zhang","year":"2023","unstructured":"Zhang, J. et al. Single-cell analysis reveals the col11a1(+) fibroblasts are cancer-specific fibroblasts that promote tumor progression. Front. Pharmacol. 14, 1121586. https:\/\/doi.org\/10.3389\/fphar.2023.1121586 (2023).","journal-title":"Front. Pharmacol."},{"key":"98661_CR13","doi-asserted-by":"publisher","first-page":"340","DOI":"10.5281\/zenodo","volume":"13","author":"JA Batsis","year":"2019","unstructured":"Batsis, J. A. et al. Development and usability assessment of a connected resistance exercise band application for strength-monitoring. World Acad. Sci. Eng. Technol. 13, 340\u2013348. https:\/\/doi.org\/10.5281\/zenodo (2019).","journal-title":"World Acad. Sci. Eng. Technol."},{"key":"98661_CR14","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1002\/gcc.22006","volume":"52","author":"M Bierkens","year":"2013","unstructured":"Bierkens, M. et al. Focal aberrations indicate eya2 and hsa-mir-375 as oncogene and tumor suppressor in cervical carcinogenesis. Genes Chromosomes Cancer 52, 56\u201368. https:\/\/doi.org\/10.1002\/gcc.22006 (2013).","journal-title":"Genes Chromosomes Cancer"},{"key":"98661_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12030757","author":"E Ben-Ami","year":"2020","unstructured":"Ben-Ami, E. et al. Lrrc15 targeting in soft-tissue sarcomas: Biological and clinical implications. Cancers https:\/\/doi.org\/10.3390\/cancers12030757 (2020).","journal-title":"Cancers"},{"key":"98661_CR16","doi-asserted-by":"publisher","first-page":"3556","DOI":"10.1158\/1078-0432.CCR-20-4513","volume":"27","author":"GD Demetri","year":"2021","unstructured":"Demetri, G. D. et al. First-in-human phase i study of abbv-085, an antibody-drug conjugate targeting lrrc15, in sarcomas and other advanced solid tumors. Clin. Cancer Res. 27, 3556\u20133566. https:\/\/doi.org\/10.1158\/1078-0432.CCR-20-4513 (2021).","journal-title":"Clin. Cancer Res."},{"key":"98661_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1038\/s41586-022-05272-1","volume":"611","author":"AT Krishnamurty","year":"2022","unstructured":"Krishnamurty, A. T. et al. Lrrc15(+) myofibroblasts dictate the stromal setpoint to suppress tumour immunity. Nature 611, 148\u2013154. https:\/\/doi.org\/10.1038\/s41586-022-05272-1 (2022).","journal-title":"Nature"},{"key":"98661_CR18","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. Kegg: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"98661_CR19","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951. https:\/\/doi.org\/10.1002\/pro.3715 (2019).","journal-title":"Protein Sci."},{"key":"98661_CR20","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. Kegg for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592. https:\/\/doi.org\/10.1093\/nar\/gkac963 (2023).","journal-title":"Nucleic Acids Res."},{"key":"98661_CR21","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/BCTT.S69488","volume":"8","author":"J Collignon","year":"2016","unstructured":"Collignon, J., Lousberg, L., Schroeder, H. & Jerusalem, G. Triple-negative breast cancer: Treatment challenges and solutions. Breast Cancer Targets Ther. 8, 93\u2013107. https:\/\/doi.org\/10.2147\/BCTT.S69488 (2016).","journal-title":"Breast Cancer Targets Ther."},{"key":"98661_CR22","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15071796","author":"O Obidiro","year":"2023","unstructured":"Obidiro, O., Battogtokh, G. & Akala, E. O. Triple negative breast cancer treatment options and limitations: Future outlook. Pharmaceutics https:\/\/doi.org\/10.3390\/pharmaceutics15071796 (2023).","journal-title":"Pharmaceutics"},{"key":"98661_CR23","doi-asserted-by":"publisher","first-page":"5933","DOI":"10.1128\/JVI.02273-07","volume":"82","author":"J O\u2019Prey","year":"2008","unstructured":"O\u2019Prey, J., Wilkinson, S. & Ryan, K. M. Tumor antigen lrrc15 impedes adenoviral infection: implications for virus-based cancer therapy. J. Virol. 82, 5933\u20135939. https:\/\/doi.org\/10.1128\/JVI.02273-07 (2008).","journal-title":"J. Virol."},{"key":"98661_CR24","doi-asserted-by":"publisher","first-page":"756","DOI":"10.1006\/bbrc.2001.6272","volume":"290","author":"K Satoh","year":"2002","unstructured":"Satoh, K., Hata, M. & Yokota, H. A novel member of the leucine-rich repeat superfamily induced in rat astrocytes by beta-amyloid. Biochem. Biophys. Res. Commun. 290, 756\u2013762. https:\/\/doi.org\/10.1006\/bbrc.2001.6272 (2002).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"98661_CR25","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2021.12518","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Cancer-associated fibroblast-derived lrrc15 promotes the migration and invasion of triple-negative breast cancer cells via wnt\/beta-catenin signalling pathway regulation. Mol. Med. Rep. https:\/\/doi.org\/10.3892\/mmr.2021.12518 (2022).","journal-title":"Mol. Med. Rep."},{"key":"98661_CR26","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1158\/0008-5472.CAN-21-0622","volume":"82","author":"U Ray","year":"2022","unstructured":"Ray, U. et al. Targeting lrrc15 inhibits metastatic dissemination of ovarian cancer. Can. Res. 82, 1038\u20131054. https:\/\/doi.org\/10.1158\/0008-5472.CAN-21-0622 (2022).","journal-title":"Can. Res."},{"key":"98661_CR27","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1158\/1535-7163.MCT-20-0406","volume":"20","author":"P Hingorani","year":"2021","unstructured":"Hingorani, P. et al. Abbv-085, antibody-drug conjugate targeting lrrc15, is effective in osteosarcoma: A report by the pediatric preclinical testing consortium. Mol. Cancer Ther. 20, 535\u2013540. https:\/\/doi.org\/10.1158\/1535-7163.MCT-20-0406 (2021).","journal-title":"Mol. Cancer Ther."},{"key":"98661_CR28","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1530\/JOE-10-0377","volume":"209","author":"SH Kim","year":"2011","unstructured":"Kim, S. H., Turnbull, J. & Guimond, S. Extracellular matrix and cell signalling: the dynamic cooperation of integrin, proteoglycan and growth factor receptor. J. Endocrinol. 209, 139\u2013151. https:\/\/doi.org\/10.1530\/JOE-10-0377 (2011).","journal-title":"J. Endocrinol."},{"key":"98661_CR29","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1038\/s41568-018-0038-z","volume":"18","author":"H Hamidi","year":"2018","unstructured":"Hamidi, H. & Ivaska, J. Every step of the way: integrins in cancer progression and metastasis. Nat. Rev. Cancer 18, 533\u2013548. https:\/\/doi.org\/10.1038\/s41568-018-0038-z (2018).","journal-title":"Nat. Rev. Cancer"},{"key":"98661_CR30","doi-asserted-by":"publisher","first-page":"2905","DOI":"10.1002\/ijc.25942","volume":"129","author":"JJ Grzesiak","year":"2011","unstructured":"Grzesiak, J. J. et al. Knockdown of the beta(1) integrin subunit reduces primary tumor growth and inhibits pancreatic cancer metastasis. Int. J. Cancer 129, 2905\u20132915. https:\/\/doi.org\/10.1002\/ijc.25942 (2011).","journal-title":"Int. J. Cancer"},{"key":"98661_CR31","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13046-018-0694-6","volume":"37","author":"J Luo","year":"2018","unstructured":"Luo, J. et al. 14, 15-eet induces breast cancer cell emt and cisplatin resistance by up-regulating integrin alphavbeta3 and activating fak\/pi3k\/akt signaling. J. Exp. Clin. Cancer Res. 37, 23. https:\/\/doi.org\/10.1186\/s13046-018-0694-6 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"98661_CR32","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202001057","author":"TM Grimm","year":"2020","unstructured":"Grimm, T. M., Dierdorf, N. I., Betz, K., Paone, C. & Hauck, C. R. Ppm1f controls integrin activity via a conserved phospho-switch. J. Cell Biol. https:\/\/doi.org\/10.1083\/jcb.202001057 (2020).","journal-title":"J. Cell Biol."},{"key":"98661_CR33","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1161\/ATVBAHA.123.319119","volume":"43","author":"Y Yu","year":"2023","unstructured":"Yu, Y. et al. Extracellular matrix stiffness regulates microvascular stability by controlling endothelial paracrine signaling to determine pericyte fate. Arterioscler. Thromb. Vasc. Biol. 43, 1887\u20131899. https:\/\/doi.org\/10.1161\/ATVBAHA.123.319119 (2023).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"98661_CR34","doi-asserted-by":"publisher","DOI":"10.3390\/biom12081036","author":"P Coopman","year":"2022","unstructured":"Coopman, P. Protein phosphorylation in cancer: Unraveling the signaling pathways. Biomolecules https:\/\/doi.org\/10.3390\/biom12081036 (2022).","journal-title":"Biomolecules"},{"key":"98661_CR35","doi-asserted-by":"publisher","first-page":"4415","DOI":"10.1242\/jcs.02565","volume":"118","author":"A Hamadi","year":"2005","unstructured":"Hamadi, A. et al. Regulation of focal adhesion dynamics and disassembly by phosphorylation of fak at tyrosine 397. J. Cell Sci. 118, 4415\u20134425. https:\/\/doi.org\/10.1242\/jcs.02565 (2005).","journal-title":"J. Cell Sci."},{"key":"98661_CR36","doi-asserted-by":"publisher","first-page":"10148","DOI":"10.1073\/pnas.91.21.10148","volume":"91","author":"HC Chen","year":"1994","unstructured":"Chen, H. C. & Guan, J. L. Association of focal adhesion kinase with its potential substrate phosphatidylinositol 3-kinase. Proc. Natl. Acad. Sci. U. S. A. 91, 10148\u201310152. https:\/\/doi.org\/10.1073\/pnas.91.21.10148 (1994).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"98661_CR37","doi-asserted-by":"publisher","first-page":"26329","DOI":"10.1074\/jbc.271.42.26329","volume":"271","author":"HC Chen","year":"1996","unstructured":"Chen, H. C., Appeddu, P. A., Isoda, H. & Guan, J. L. Phosphorylation of tyrosine 397 in focal adhesion kinase is required for binding phosphatidylinositol 3-kinase. J. Biol. Chem. 271, 26329\u201326334. https:\/\/doi.org\/10.1074\/jbc.271.42.26329 (1996).","journal-title":"J. Biol. Chem."},{"key":"98661_CR38","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12739","volume":"53","author":"J Zhou","year":"2020","unstructured":"Zhou, J., Jiang, Y. Y., Chen, H., Wu, Y. C. & Zhang, L. Tanshinone i attenuates the malignant biological properties of ovarian cancer by inducing apoptosis and autophagy via the inactivation of pi3k\/akt\/mtor pathway. Cell Prolif. 53, e12739. https:\/\/doi.org\/10.1111\/cpr.12739 (2020).","journal-title":"Cell Prolif."},{"key":"98661_CR39","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03614-1","author":"Y Leng","year":"2024","unstructured":"Leng, Y. et al. Ppm1f regulates ovarian cancer progression by affecting the dephosphorylation of itgb1. Clin. Transl. Oncol. https:\/\/doi.org\/10.1007\/s12094-024-03614-1 (2024).","journal-title":"Clin. Transl. Oncol."},{"key":"98661_CR40","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.16679","volume":"11","author":"X Wen","year":"2023","unstructured":"Wen, X., Hou, Y., Zhou, L. & Fang, X. Linc00969 inhibits proliferation with metastasis of breast cancer by regulating phosphorylation of pi3k\/akt and ilp2 expression through hoxd8. PeerJ 11, e16679. https:\/\/doi.org\/10.7717\/peerj.16679 (2023).","journal-title":"PeerJ"}],"updated-by":[{"DOI":"10.1038\/s41598-026-77598-z","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:00:00Z","timestamp":1792972800000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98661-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98661-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98661-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T21:03:07Z","timestamp":1793048587000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-98661-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["98661"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-98661-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]},"assertion":[{"value":"14 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This article has been retracted. Please see the Retraction Notice for more detail:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-026-77598-z","URL":"https:\/\/doi.org\/10.1038\/s41598-026-77598-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study is performed in accordance with relevant guidelines and regulations. All animal use procedures were in accordance with the Guide for the Care and Use of Laboratory Animals (NIH publications no. 80-23, revised 1996) and were performed according to the institutional ethical guidelines for animal experiments. Certificate number [2022] No. 274 was used for the animal experiments. Animals were sacrificed using CO2 asphyxiation. This study was approved by the Ethics Committee of the First Affiliated Hospital of Bengbu Medical College [2022] No. 180. We confirmed that informed consent was obtained from all subjects and\/or their legal guardian(s).","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"14535"}}